{"id":"https://openalex.org/W2149296540","doi":"https://doi.org/10.1093/jac/dkr098","title":"Review of ceftaroline fosamil microbiology: integrated FOCUS studies","display_name":"Review of ceftaroline fosamil microbiology: integrated FOCUS studies","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2149296540","doi":"https://doi.org/10.1093/jac/dkr098","mag":"2149296540","pmid":"https://pubmed.ncbi.nlm.nih.gov/21482569"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkr098","doi":"https://doi.org/10.1093/jac/dkr098","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkr098","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063814702","display_name":"Ian A. Critchley","orcid":"https://orcid.org/0000-0003-0981-0758","observed_orcids":["https://orcid.org/0000-0003-0981-0758"]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"I. A. Critchley","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA 94612, USA. icritchley@cerexa.com","Cerexa, Inc., Oakland, CA 94612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA. icritchley@cerexa.com","institution_ids":["https://openalex.org/I4405273071"]},{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031780287","display_name":"Paul B. Eckburg","orcid":"https://orcid.org/0000-0001-6133-9057","observed_orcids":["https://orcid.org/0000-0001-6133-9057"]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. B. Eckburg","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA 94612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049961467","display_name":"Alena Jandourek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Jandourek","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA 94612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113550069","display_name":"Donald P. Biek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Biek","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA 94612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058653363","display_name":"Hillel David Friedland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. D. Friedland","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA 94612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053400330","display_name":"Dirk A. Thye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. A. Thye","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA 94612, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA 94612, USA","institution_ids":["https://openalex.org/I4405273071"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063814702"],"corresponding_institution_ids":["https://openalex.org/I4405273071"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":5.2166,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.95933991,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"66","issue":"Supplement 3","first_page":"iii45","last_page":"iii51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.09839999675750732,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.07500000298023224,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftaroline-fosamil","display_name":"ceftaroline fosamil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ceftaroline","display_name":"ceftaroline","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.8050000071525574},{"id":"https://openalex.org/keywords/community-acquired-pneumonia","display_name":"community-acquired pneumonia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/streptococcus-pneumoniae","display_name":"Streptococcus pneumoniae","score":0.9739999771118164},{"id":"https://openalex.org/keywords/haemophilus-influenzae","display_name":"Haemophilus influenzae","score":0.996999979019165},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.9869999885559082},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.9160000085830688},{"id":"https://openalex.org/keywords/penicillin-resistance","display_name":"penicillin resistance","score":0.7179999947547913},{"id":"https://openalex.org/keywords/multidrug-resistant-streptococcus-pneumoniae","display_name":"multidrug-resistant Streptococcus pneumoniae","score":0.8190000057220459},{"id":"https://openalex.org/keywords/beta-lactamase","display_name":"beta-lactamase","score":0.7400000095367432},{"id":"https://openalex.org/keywords/penicillin-binding-proteins","display_name":"penicillin-binding proteins","score":0.9269999861717224},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.8820000290870667},{"id":"https://openalex.org/keywords/microbiological-response","display_name":"microbiological response","score":0.5809999704360962},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.5320000052452087},{"id":"https://openalex.org/keywords/gram-negative-pathogens","display_name":"Gram-negative pathogens","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.764680027961731},{"id":"https://openalex.org/C2776925733","wikidata":"https://www.wikidata.org/wiki/Q1141979","display_name":"Haemophilus influenzae","level":3,"score":0.6851151585578918},{"id":"https://openalex.org/C2781253189","wikidata":"https://www.wikidata.org/wiki/Q221179","display_name":"Streptococcus pneumoniae","level":3,"score":0.6648529767990112},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.6031004786491394},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.5909385085105896},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.5712740421295166},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4987521171569824},{"id":"https://openalex.org/C2777052132","wikidata":"https://www.wikidata.org/wiki/Q595158","display_name":"Methicillin-resistant Staphylococcus aureus","level":4,"score":0.4812902510166168},{"id":"https://openalex.org/C2776460866","wikidata":"https://www.wikidata.org/wiki/Q170065","display_name":"Pathogen","level":2,"score":0.45039480924606323},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.43881407380104065},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27933061122894287},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.16001805663108826},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097583","descriptor_name":"Ceftaroline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006090","descriptor_name":"Gram-Negative Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006090","descriptor_name":"Gram-Negative Bacteria","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006094","descriptor_name":"Gram-Positive Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006094","descriptor_name":"Gram-Positive Bacteria","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017714","descriptor_name":"Community-Acquired Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017714","descriptor_name":"Community-Acquired Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/dkr098","doi":"https://doi.org/10.1093/jac/dkr098","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkr098","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:21482569","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21482569","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.832.8258","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.832.8258","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jac.oxfordjournals.org/content/66/suppl_3/iii45.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306606","display_name":"American Thoracic Society","ror":"https://ror.org/0547sz392"},{"id":"https://openalex.org/F4320332245","display_name":"Forest Laboratories","ror":"https://ror.org/03pfqk412"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1585621008","https://openalex.org/W1843601581","https://openalex.org/W1971597586","https://openalex.org/W1981158065","https://openalex.org/W2004627090","https://openalex.org/W2012617927","https://openalex.org/W2029733998","https://openalex.org/W2068575722","https://openalex.org/W2069153240","https://openalex.org/W2069223847","https://openalex.org/W2077441600","https://openalex.org/W2096456694","https://openalex.org/W2120704894","https://openalex.org/W2130141864","https://openalex.org/W2131604777","https://openalex.org/W2132212568","https://openalex.org/W2132813534","https://openalex.org/W2135191756","https://openalex.org/W2147653151","https://openalex.org/W2150965448","https://openalex.org/W2155965882","https://openalex.org/W2156956165","https://openalex.org/W2163909934","https://openalex.org/W2166038140","https://openalex.org/W2187646101","https://openalex.org/W2315571627","https://openalex.org/W2916433178"],"related_works":["https://openalex.org/W2149940840","https://openalex.org/W2144012207","https://openalex.org/W2065590100","https://openalex.org/W1982839622","https://openalex.org/W2162006653","https://openalex.org/W7097981752","https://openalex.org/W2103158733","https://openalex.org/W1977765387","https://openalex.org/W1992019555","https://openalex.org/W2326102744"],"abstract_inverted_index":{"Ceftaroline":[0,96],"fosamil,":[1],"the":[2,88,116,148,153],"prodrug":[3],"form":[4],"of":[5,56,82,90,118,177,221,238],"ceftaroline,":[6,218],"is":[7,61,84],"a":[8,232],"novel":[9],"broad-spectrum":[10],"parenteral":[11],"cephalosporin":[12],"that":[13],"exhibits":[14],"antibacterial":[15],"activity":[16,37,55,81],"against":[17,38,58],"typical":[18],"respiratory":[19,127],"pathogens":[20,204],"such":[21,205],"as":[22,48,50,206,231],"Streptococcus":[23],"pneumoniae,":[24,47,187,208],"Haemophilus":[25],"influenzae,":[26],"Staphylococcus":[27],"aureus":[28,214],"and":[29,44,104,135,141,179,183,189,194,196,211,224],"common":[30],"Gram-negative":[31],"pathogens.":[32],"In":[33],"particular,":[34],"ceftaroline":[35,57,83,164,178],"has":[36],"resistant":[39],"Gram-positive":[40],"cocci,":[41],"including":[42],"penicillin-":[43],"multidrug-resistant":[45],"S.":[46,52,186,199,207,213],"well":[49],"methicillin-resistant":[51],"aureus.":[53],"The":[54,80,156,172],"these":[59],"phenotypes":[60],"attributed":[62],"to":[63,66,68,93,217],"its":[64,229],"ability":[65,89],"bind":[67],"modified":[69],"penicillin-binding":[70],"proteins":[71],"with":[72,77,100,168,219],"high":[73],"affinity":[74],"when":[75],"compared":[76,99,167],"other":[78],"\u03b2-lactams.":[79],"not":[85],"compromised":[86],"by":[87,161],"H.":[91,192,209],"influenzae":[92,193,210],"produce":[94],"\u03b2-lactamase.":[95],"fosamil":[97],"was":[98],"ceftriaxone":[101,180],"for":[102,115,163,170,185,191,198,236],"safety":[103],"efficacy":[105],"in":[106,147],"two":[107],"randomized,":[108],"double-blinded,":[109],"controlled":[110],"Phase":[111],"III":[112],"clinical":[113],"trials":[114],"treatment":[117,237],"community-acquired":[119],"pneumonia":[120],"(CAP).":[121],"Microbiological":[122],"assessments":[123],"at":[124,152],"baseline":[125,203],"included":[126],"specimen":[128],"cultures,":[129,131],"blood":[130],"urinary":[132],"antigen":[133],"testing":[134],"atypical":[136],"pathogen":[137],"serology":[138],"testing.":[139],"By-subject":[140],"by-pathogen":[142,173],"microbiological":[143,158,174],"outcomes":[144],"were":[145,165,181,215],"assessed":[146],"microbiologically":[149],"evaluable":[150],"population":[151],"test-of-cure":[154],"visit.":[155],"favourable":[157],"response":[159,175],"rates":[160,176],"subject":[162],"87.0%":[166],"81.0%":[169],"ceftriaxone.":[171],"87.3%":[182],"72.9%":[184],"83.3%":[188],"85.0%":[190],"76.0%":[195],"70.4%":[197],"aureus,":[200],"respectively.":[201],"Key":[202],"methicillin-susceptible":[212],"susceptible":[216],"MIC(90)s":[220],"0.03,":[222],"0.03":[223],"0.25":[225],"mg/L,":[226],"respectively,":[227],"supporting":[228],"utility":[230],"promising":[233],"new":[234],"agent":[235],"CAP.":[239]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}